{"ticker": {"uuid": "7bb72e3e-f732-4308-b18d-13845b1a4811", "symbol": "RXRX", "name": "RECURSION PHARMACEUTICALS INC", "exchange": "MEX", "country": "MX", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Recursion Pharmaceuticals Stock Short Interest Falls to 34.41%", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPbE9YRFZZRFVrVjdya0lDMGtVNjFTUWE1OUM4S0hJNDAybVdUaU01UElydjlEX1BscEx1UGROTV8yN2tVRllyS0RpOGZ5WFN1eWx2Rlp4eXlGNnJBcnZfNGVLUUV0aWltWFFoRERMeWc0aDZVT3RqRTBLQk9fcV9KOGJrUFJGaFJsaDdYWEFEMm9EYklTaVI4XzBEZVNmUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-21T13:28:00+00:00", "published_display": "21 Jul 2026 13:28", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals (RXRX) Falls More Steeply Than Broader Market: What Investors Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNbGhGSmZQN2U3ZGNNOFNDRnRMUkgtbTdoM016dzh0Y1FWb295cFp6Q0J6eTVELTJHNWtJRlA3QkxyUVdkZkFJbWRheW10S0pXNE1DVDJDNjB6d2M1RDJ0NUJFOEFCTWY1UFFsTmNXLTlhd0dlRGJlZlNqbFJOR09YTEN0N1EweFhPZml1M0NPMnNQb1RE?oc=5", "source_name": "Market source", "published_at": "2026-07-20T21:50:04+00:00", "published_display": "20 Jul 2026 21:50", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has \u2018Reached An Inflection Point\u2019", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxNd0hKNF84emhiVl9UbDhYOWQtdl9jV2JYZmduUy1QV2haQ3RBeXlpWjNiMDV3SUpBZVFGOEE2Tmd5QUNYV2lDLVdFOVg3SFZ4enA1YnJMWmVVaUl2VUVOSlZnSUtjdnBoY1ZaZURVVm84RTU0UHdXaUFXbTZOYmo5S3BRSnlvakVraElJZmZVOUtYeEQ4em1SUVJkdG1lcHh5U0FmRzMwX0dua0FjdEE5TGRzMXUxX1phLUpQWHRDTXZWR205cm9kQUUwbUlVQ0RmalBB?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-18T14:24:55+00:00", "published_display": "18 Jul 2026 14:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Recursion Pharmaceuticals (RXRX) Outpaced the Stock Market Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPdFVJOVZ4WUY2OVNRNnk2R1ZBdnRVNVJKa2RzQS1PY2J3SzVDWFpkY2tqakVSb0djUkZnVlhmS2pCWWhnZ01VcnpoaTNZSGhVaEZ6eEFCakJ2OWtGaU8yT1dIbTBmcmJFbVE2RzFaYlB6WVBWS240WndoTzVFbGU0cDl2WkVVX09wXzhTYklldzZKTktOM29YUGNxa0tDanc5OG4wQ0lPVG1XMjh5?oc=5", "source_name": "Market source", "published_at": "2026-07-14T21:50:03+00:00", "published_display": "14 Jul 2026 21:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals Stock (RXRX) Opinions on Biotech AI Prospects", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNbXpjT29EVjlXQTRDY2FRVk41TjF1Nlh0RTcxWW9Dc1R6VDFjVUtNLXVEamlhUGRQNVk0bnV0cEtyNElvNEtMWUxBcUtKOEVXbVdwV0dTVldTc0Q4X3hWOWt0VnhBUElRdDNRcG5uVlRpNmlPbVdIMTg2OEZsVWt1VnpTaEt3cUh0Ulh1RHFMcXljendVLXZpdFR0by1yWkM3XzNkZWNiVlNiZFVn?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-10T17:37:00+00:00", "published_display": "10 Jul 2026 17:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Recursion Pharmaceuticals (RXRX) The Best Penny Stocks According to Billioanires?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQM2VTUEpBS1RvYWZndWx0M1hLb0p4dWFFclhzMjFEVjVqaGpqS3NDb2ZjR3pxUGRwazZNdlZSX1hUYWVDQm4wcmlYZzJ5VkZoMmNscGlYeDZzS0wyMkp6TmVWdGktSWJyT0dXWWhZZWpHaXk0WXlzWmY2azZYYktUdHBjUG5IQmYySUMyOXVJb0FWZFpJdXI3SGMyQU91Uk15TjQ3bQ?oc=5", "source_name": "Market source", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals (RXRX) Stock Looks Fully Valued Despite AI Drug Hopes", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNa1hrRnktb2hsS0I5VDhXam4zRXpyUFNFd1FGSGFCcl9rQlpPanpadmo2dEZqU2lXeVFOSVNWTXNfMzBkMnRGNnVvMmFscXhsamgzWFlPdmR5ZV9BVE9JNFVLLVpSMXNEVFRhTHBPQkJqSXI4d3pkTnBic2ozWlVkTEdNWGk1ZUFUUlRnbVVxbElEWHMzbHZXbU5NemVBcVg5VHF3bUVZa01Scjg?oc=5", "source_name": "Market source", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxQaEJVSTZTUDlNQVBSQlJvbDhsS3JaTVQ2OGxZUzRoLWFfaUh2ZUdxamVjcjNneUM3QVFLQU1Ca3dGUnpmUmZmandudHQtT2FnTTFwUF9OWnpkczRSUXJvemV2T2NMU0JSWmZydFpfR3FUeHRGbGh4cEVVVVZIU1gxcy1pS084bXY0d2l2cUluRVlDT20zUGdrM1JDRVRueWtheVc3MFJhWjZBWkFXRlR6TlRPS0hHNm9jVURJVWVsYzRuRVJaUUVEN3ZGR2EwbmxJcjIzQWQ3a2dJNEtPZDZsc1pzMGVNSjNaMl8zdFR0YjRBQQ?oc=5", "source_name": "The Motley Fool", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOdW9SNkxERTByZkVjQ1hxLTlyVjhjVUtiMzVPRC1YOTVZd3R3T01ZZ3A2b3dzaUNyOVEza3JoY1lTN3N2WUZqZGduWG5YWW5CUWFiM2ROYVktQm5fT3Y1Yl84OWZVbnEtSXRsMmREUkJiQnBwbFlNMW5SckkzV0hBbXpfc2xxWS1jN1RBMDBwNzA1UDhCbzQwRFpFZlZhVUtzNG9QcmRPM3N6Wk9LSlJoWDdWRVpCZkk5YVpfUXFFalZHbEQweWF1OA?oc=5", "source_name": "The Motley Fool", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxNR1dwU3ZUbkZ4d1A1SXN0eEg2WDBlT1pxNDlxbjNHYVI0Vk9oUDA4NDJIOHdjQlgtRjNrLVViVU1GcUxCTWZMVnpaeUNXRnhMeDVJSThFNnpqYzhxTTd3UjJfUnpjWXU2bWJnME1RbzZfV2FNZWZuRWJpRkhfVG0xMXJuTEthYTA3NUI4OWhHVlVidjNzR2w1Y0psUmU4V1R3VkhOZHdyMWhjOEhkQk0wMkIxZ0V1UjAyUmM3OFhvQlZvN3RIRF9abnNzM09uRFdFeFJoalphVDZMRHVWN0VIZzRR?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals Stock (RXRX) Opinions on ARK Invest's Recent Share Purchase", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOQy1EQkxoUVlXN3czcHk1d0c5TlZ5b25fWm1hZ01ZUVFCc0xOekxtZ3Zwc0Vjc3lLWFVqZ1ZsLVQ5eXhqb1EwVm90cDIxd3hEc1BuZG1vMVd3ZVdRemlPMVpFTjl3OTlYTEFjN0dvYjZiY1M0NC11UEJtWm9VNG1Pb2NyWERrMUpVSkdpaGUzdDBTTUluSHFGRThvN29SWmVxVUVlZzFiNnExU0ZSb0hvMkVHMzEta1dHbkN0a01SWHhRUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals (RXRX) Ascends While Market Falls: Some Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOOEpKOENaUGtoTm5xaVdTLVdhSENyZjBxeUVyYUs3Q3NhTlk0bkRpUFdZRTFfWUw3WnMxcS1LSVNxUC15em4tZzJsQmxzeWJESWVLT1FkX1VFcVN1MmRvX3I0VXpTSjJMdWxLYVlmZTFyTXpQN25SU0hRWG8zWUVkNjFVVWRqWXduc1ZnTmRSQVQ5em1HTzVhN0l0enBWRUtoNTJDaVY0c2VtYVk4aXc?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals (RXRX) Stock Valuation After AI Drug Discovery And REC-1245 REC-4881 Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPSGpmZUF3UTNPdUFtLVlBQWJlQU9RVVpManZDNFJyYXdPRlVjVGZsaTRnU3ltYU9Pdkx5US14ekphUFdaVTlCQmV6VGoxYjR2RGotQ3plLWJocWZRMXlzMjFMTWdXUjNYamM2clZaQXh6NDhvUWJCRnIxbUl1YTJ0WXdzR2xXR1pMeHlxazdReE5rSU9uM2xNdVd2eElQRnJrUTRILTZORDV2LWE1a0hFUlVfZ0xWZw?oc=5", "source_name": "Market source", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals (RXRX) Up 16.2% Since Last Earnings Report: Can It Continue?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxObk5Dbkc3Y0xPSURiQVFuRzRHdHl2b0dDMEIzM3ZrN2x3ZDlKNFA1b1FPRHpMb2Z3MnBKV1NTdzMxSG5FNXpWT1JQd1JCR3NhVF9FZzZSeDZkeFhHSTUxcFVkRVY4Tm5pUEFjRXI4eE5IWW1YRktYUFg3ejZJcU9tNHhjanZ2eXNRT2FTRzdDZTJGUERWdXQ5VUljbDdjZTVPdmc?oc=5", "source_name": "Market source", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley Raises its Price Target on Recursion (RXRX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPU0lzTDZJZGZIeGdmS19oUllYdEM0bE5mRG5DNl9RYUwzT1oxeWNHbE85Q09ySUQ1MVVkV2U4RGNXRmRuQVVBMHJsTzlsbnVpVWpMSWRTeW9FZW5pMjNpbXJQODZ3ak1IUXBwZk9EUHBrUnVzbWJRcmFmLWZOSzN1ZlNXR1JoTm9idWxjOWhWelY1cTZ2MGVKZmNHWXVwaTVad3Z6SDRn?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals (RXRX) Stock Drops Despite Market Gains: Important Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQWWhnY0RTX2pXa1AwbnNXcXR3SHlLdFlfQjBlS0NtTVE3eUZ3WjJrTXhUbTgxeXdYaXJ4YnJ6REl4eWs5NnpISG9UWEg0aG13dmtsTHg0SU5wR0Q2MDAyc3djcThQSnlDaGRJQ25XQWdjb3NBa1g3VWJXNDNzY1FEMjJDenVfUXMyR0FLZEQ5UEgxLXRCcnlCY0p3ak1qY1dGOElTZUNCYjJ5REk?oc=5", "source_name": "Market source", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RXRX Stock: Why Did Nvidia Offload AI Drug Developer Recursion?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPNGd2VElrallVa05DLXNhR09rdWNwOUlTdi1GUHJBXzVneml5OWdfWXhNdHZzbVdvXzVoVGpwa3dia3o1TDA0YXB5aHZvR21qUFNNVnJHYXQ0TjJSbEpFZE5MV3prWDJZZ3JkTk9IMTlneHdOc2pVdmdVdTFCbExpeHF3ZmFJOEFpWmdCVjJKaUF2T0dVRWZTR3V3QUR6Zw?oc=5", "source_name": "CMC Markets", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has 'Reached An Inflection Point'", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNbzBrak5aTnJlR2Rnb2p6eWExR3Q5dnV4T1pyRkVjTk0xc0pEWklFLWpDMDdGdXU2Zkh6Y1lTQXRUMF9GaThKTFJXVFpiLXRuU0FZUWxBTlZkRFlLZ0phQnd2aFUyVnNVOWl0dGlkcHV6VG15bGludTBMMFp1dngxaGxNX1ZaSE5ZX25ZU2hEVzdmUnVjUmFmc1hBMW1Da253ZzZlSEtHNk9UNTFXNE5BUGp4RkpJZWNRQmpmWExTaVpMc0MxS1E?oc=5", "source_name": "Menafn", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nvidia Dumped Recursion Pharmaceuticals Stock. Should You?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNRWlyZll6MVJ5N09uc0daaDF5a25EYk12Qnh2YUZSTzJIRWN1V0gwRXQ1MWRNemt3SWpvc21LbW90dWgzQVNvMEh4OUxNMERVTGRlNGlGVk9Tb3NJbnlmajNhOGZjT1JoLVFvMXBSbFRCWE9pdXVvdVplblhocjg5TkdDY2pOT094VlRncFEyR3FWaWRxZzlDeDNmSjY1eHRG?oc=5", "source_name": "Barchart.com", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cathie Wood Is Doubling Down on Recursion Pharmaceuticals Stock. Should You Buy RXRX Here?", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPazJjMkZ5QmVqTHd6VmZpODRaMTdSQUQzWjh0OHY4ejVCVFdnN1p6alhWWWhqMTlfX1FTYjdnTjg3bk51QnpfeUo0TGdDWDVlNHdRanJyaml4eEIybUtwVkNQbFRnYWdULURDUGpjN08yZjhpM0kxcFBVVWJwbDB4QXZCS0ZLeTdVSmVSN0l3blBESS1Iem1FQnNwVkszZUp6OVZVMWtDNG9ObEhydFdybWJpYUV5cmIyX0dmV3dkN1EtSlFVUnhCUngxZnZsUQ?oc=5", "source_name": "Barchart.com", "published_at": "2025-12-24T08:00:00+00:00", "published_display": "24 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oracle, Hut 8, Processa Pharmaceuticals, Recursion Pharmaceuticals, Udemy: Stocks Making The Biggest Moves Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPeDZPLTdWSXo5aHFadkN2a29oSWprcmt4WVYwTksxSXFaUGFUV2xNLVNjWDI3d0t5aUIydk1WV2RfV3lOckZQS0dWU3k5X0hRLVAyMHRZbXJmN0VIdVhmZnNLLXJBUGJ4bVdsVGJzYTAyQ1ZvYzdRVURnVzRBSFdicEVDMjRySmNlZnVxLW84djBqUjE5dmVFZE81cVBRd25mWjBMcWZ2TEozZkp2TU5wSFk5bnp0N0EtSkE?oc=5", "source_name": "Stocktwits", "published_at": "2025-12-17T08:00:00+00:00", "published_display": "17 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals Stock: Growth or Bubble?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNUGJuLVBFVnU2a19ZM05tdzhZZHFyOHh3aXVLU2tHSEpONHJvTmtvTEFpMVU3ZFIxSDFoQjR5Z2thcnBlcy0zQlBKeUd0ZEVoc2h2bjFLdWwzSDF1N282ckxMREJCeUxjSmh6c2tLVEZRamhtSWU0bGpaY0NUUkx5Z09oNnZkMG8xaEE?oc=5", "source_name": "StocksToTrade", "published_at": "2025-10-22T07:00:00+00:00", "published_display": "22 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tempus AI (TEM) vs. Recursion (RXRX): Which AI Biotech Stock Is Better?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNZ2xsckxkTVFVU2hPeHdLcjBQR0cwYnhCdXJLajVIY1UzNHUwakpFZmtpSDF4dHZkalBSS2JpYXNmajVzRllKOV9fLVdWbkhjSFA2Nl9jSGNHd083c2JwZ05sZHBVUkl6UDQwZVNGbnZjMWVwUDFQODJBRU5zdDZLaTdaTElwdS1RX0xiYlVwUlhFUEtoMzhKaEhWQlE3dmtyRV9zT19XcEZTZ2pM?oc=5", "source_name": "24/7 Wall St.", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals Stock Price Forecast. Should You Buy RXRX?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTE01VFBYVXh6X3owY052bGxSOV9yRGs2bzNpWjN2eXVBeHdxX2g0Z0RyUE1DXzB5NjlGandfNnd2eFZvRW5CeXRUVQ?oc=5", "source_name": "StockInvest.us", "published_at": "2021-04-27T19:48:12+00:00", "published_display": "27 Apr 2021 19:48", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals Announces Pricing of Initial Public Offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNR0N0Vmc3aEZTMlVZRFFyMVlvVEpjM2RXbkJJRzk0WXBDaEliVHNNU0lhLWROdTI3TnhJR1FWUTBTa3owclhhVmpxcVFxLWtld3c3aXJmcDlCbjlpa3c2aGtaZGdGOVVXTWlwWE9WNXhMVHN0ODM5VE1jRV93UndHYkp4WWlBY0xYRlhRVjcwOWRYcGZlVm5VZzVwclN6WGh4eDNwQ1RaVjhQZ0Z4VG1fVmIzdnZiS0lfR2lBNHJ0YWN4S0Nt?oc=5", "source_name": "PR Newswire", "published_at": "2021-04-16T07:00:00+00:00", "published_display": "16 Apr 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals Jumps in Debut After $436 Million IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOOE1VbEVtVGFYZVBVVFc4RFFUY2ZPNEJiVmZUcnVPaWZpbVAwZVA5MzNvYURkTS1qOFZjSXl0UmsxZFpIR3ZuUDZGdEJDMG9uNWoxcFNodXpPblhWaEs2S2E1bDJaY1dHdUhsa2FkaFhVZ1dzeVpoMV9tc25oSFhZdVNtTU1sd3ozYmhmZHByanRpRElCOTUxU0dnMjlhazdUblhLV0lFUlI0M1J3MDNyUkJjRQ?oc=5", "source_name": "Bloomberg.com", "published_at": "2021-04-16T07:00:00+00:00", "published_display": "16 Apr 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Recursion Pharmaceuticals Stock Short Interest Falls to 34.41%", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPbE9YRFZZRFVrVjdya0lDMGtVNjFTUWE1OUM4S0hJNDAybVdUaU01UElydjlEX1BscEx1UGROTV8yN2tVRllyS0RpOGZ5WFN1eWx2Rlp4eXlGNnJBcnZfNGVLUUV0aWltWFFoRERMeWc0aDZVT3RqRTBLQk9fcV9KOGJrUFJGaFJsaDdYWEFEMm9EYklTaVI4XzBEZVNmUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-21T13:28:00+00:00", "published_display": "21 Jul 2026 13:28", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals (RXRX) Falls More Steeply Than Broader Market: What Investors Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNbGhGSmZQN2U3ZGNNOFNDRnRMUkgtbTdoM016dzh0Y1FWb295cFp6Q0J6eTVELTJHNWtJRlA3QkxyUVdkZkFJbWRheW10S0pXNE1DVDJDNjB6d2M1RDJ0NUJFOEFCTWY1UFFsTmNXLTlhd0dlRGJlZlNqbFJOR09YTEN0N1EweFhPZml1M0NPMnNQb1RE?oc=5", "source_name": "Market source", "published_at": "2026-07-20T21:50:04+00:00", "published_display": "20 Jul 2026 21:50", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has \u2018Reached An Inflection Point\u2019", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxNd0hKNF84emhiVl9UbDhYOWQtdl9jV2JYZmduUy1QV2haQ3RBeXlpWjNiMDV3SUpBZVFGOEE2Tmd5QUNYV2lDLVdFOVg3SFZ4enA1YnJMWmVVaUl2VUVOSlZnSUtjdnBoY1ZaZURVVm84RTU0UHdXaUFXbTZOYmo5S3BRSnlvakVraElJZmZVOUtYeEQ4em1SUVJkdG1lcHh5U0FmRzMwX0dua0FjdEE5TGRzMXUxX1phLUpQWHRDTXZWR205cm9kQUUwbUlVQ0RmalBB?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-18T14:24:55+00:00", "published_display": "18 Jul 2026 14:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Recursion Pharmaceuticals (RXRX) Outpaced the Stock Market Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPdFVJOVZ4WUY2OVNRNnk2R1ZBdnRVNVJKa2RzQS1PY2J3SzVDWFpkY2tqakVSb0djUkZnVlhmS2pCWWhnZ01VcnpoaTNZSGhVaEZ6eEFCakJ2OWtGaU8yT1dIbTBmcmJFbVE2RzFaYlB6WVBWS240WndoTzVFbGU0cDl2WkVVX09wXzhTYklldzZKTktOM29YUGNxa0tDanc5OG4wQ0lPVG1XMjh5?oc=5", "source_name": "Market source", "published_at": "2026-07-14T21:50:03+00:00", "published_display": "14 Jul 2026 21:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals Stock (RXRX) Opinions on Biotech AI Prospects", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNbXpjT29EVjlXQTRDY2FRVk41TjF1Nlh0RTcxWW9Dc1R6VDFjVUtNLXVEamlhUGRQNVk0bnV0cEtyNElvNEtMWUxBcUtKOEVXbVdwV0dTVldTc0Q4X3hWOWt0VnhBUElRdDNRcG5uVlRpNmlPbVdIMTg2OEZsVWt1VnpTaEt3cUh0Ulh1RHFMcXljendVLXZpdFR0by1yWkM3XzNkZWNiVlNiZFVn?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-10T17:37:00+00:00", "published_display": "10 Jul 2026 17:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Recursion Pharmaceuticals (RXRX) The Best Penny Stocks According to Billioanires?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQM2VTUEpBS1RvYWZndWx0M1hLb0p4dWFFclhzMjFEVjVqaGpqS3NDb2ZjR3pxUGRwazZNdlZSX1hUYWVDQm4wcmlYZzJ5VkZoMmNscGlYeDZzS0wyMkp6TmVWdGktSWJyT0dXWWhZZWpHaXk0WXlzWmY2azZYYktUdHBjUG5IQmYySUMyOXVJb0FWZFpJdXI3SGMyQU91Uk15TjQ3bQ?oc=5", "source_name": "Market source", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals (RXRX) Stock Looks Fully Valued Despite AI Drug Hopes", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNa1hrRnktb2hsS0I5VDhXam4zRXpyUFNFd1FGSGFCcl9rQlpPanpadmo2dEZqU2lXeVFOSVNWTXNfMzBkMnRGNnVvMmFscXhsamgzWFlPdmR5ZV9BVE9JNFVLLVpSMXNEVFRhTHBPQkJqSXI4d3pkTnBic2ozWlVkTEdNWGk1ZUFUUlRnbVVxbElEWHMzbHZXbU5NemVBcVg5VHF3bUVZa01Scjg?oc=5", "source_name": "Market source", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxQaEJVSTZTUDlNQVBSQlJvbDhsS3JaTVQ2OGxZUzRoLWFfaUh2ZUdxamVjcjNneUM3QVFLQU1Ca3dGUnpmUmZmandudHQtT2FnTTFwUF9OWnpkczRSUXJvemV2T2NMU0JSWmZydFpfR3FUeHRGbGh4cEVVVVZIU1gxcy1pS084bXY0d2l2cUluRVlDT20zUGdrM1JDRVRueWtheVc3MFJhWjZBWkFXRlR6TlRPS0hHNm9jVURJVWVsYzRuRVJaUUVEN3ZGR2EwbmxJcjIzQWQ3a2dJNEtPZDZsc1pzMGVNSjNaMl8zdFR0YjRBQQ?oc=5", "source_name": "The Motley Fool", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOdW9SNkxERTByZkVjQ1hxLTlyVjhjVUtiMzVPRC1YOTVZd3R3T01ZZ3A2b3dzaUNyOVEza3JoY1lTN3N2WUZqZGduWG5YWW5CUWFiM2ROYVktQm5fT3Y1Yl84OWZVbnEtSXRsMmREUkJiQnBwbFlNMW5SckkzV0hBbXpfc2xxWS1jN1RBMDBwNzA1UDhCbzQwRFpFZlZhVUtzNG9QcmRPM3N6Wk9LSlJoWDdWRVpCZkk5YVpfUXFFalZHbEQweWF1OA?oc=5", "source_name": "The Motley Fool", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxNR1dwU3ZUbkZ4d1A1SXN0eEg2WDBlT1pxNDlxbjNHYVI0Vk9oUDA4NDJIOHdjQlgtRjNrLVViVU1GcUxCTWZMVnpaeUNXRnhMeDVJSThFNnpqYzhxTTd3UjJfUnpjWXU2bWJnME1RbzZfV2FNZWZuRWJpRkhfVG0xMXJuTEthYTA3NUI4OWhHVlVidjNzR2w1Y0psUmU4V1R3VkhOZHdyMWhjOEhkQk0wMkIxZ0V1UjAyUmM3OFhvQlZvN3RIRF9abnNzM09uRFdFeFJoalphVDZMRHVWN0VIZzRR?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals Stock (RXRX) Opinions on ARK Invest's Recent Share Purchase", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOQy1EQkxoUVlXN3czcHk1d0c5TlZ5b25fWm1hZ01ZUVFCc0xOekxtZ3Zwc0Vjc3lLWFVqZ1ZsLVQ5eXhqb1EwVm90cDIxd3hEc1BuZG1vMVd3ZVdRemlPMVpFTjl3OTlYTEFjN0dvYjZiY1M0NC11UEJtWm9VNG1Pb2NyWERrMUpVSkdpaGUzdDBTTUluSHFGRThvN29SWmVxVUVlZzFiNnExU0ZSb0hvMkVHMzEta1dHbkN0a01SWHhRUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals (RXRX) Ascends While Market Falls: Some Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOOEpKOENaUGtoTm5xaVdTLVdhSENyZjBxeUVyYUs3Q3NhTlk0bkRpUFdZRTFfWUw3WnMxcS1LSVNxUC15em4tZzJsQmxzeWJESWVLT1FkX1VFcVN1MmRvX3I0VXpTSjJMdWxLYVlmZTFyTXpQN25SU0hRWG8zWUVkNjFVVWRqWXduc1ZnTmRSQVQ5em1HTzVhN0l0enBWRUtoNTJDaVY0c2VtYVk4aXc?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals (RXRX) Stock Valuation After AI Drug Discovery And REC-1245 REC-4881 Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPSGpmZUF3UTNPdUFtLVlBQWJlQU9RVVpManZDNFJyYXdPRlVjVGZsaTRnU3ltYU9Pdkx5US14ekphUFdaVTlCQmV6VGoxYjR2RGotQ3plLWJocWZRMXlzMjFMTWdXUjNYamM2clZaQXh6NDhvUWJCRnIxbUl1YTJ0WXdzR2xXR1pMeHlxazdReE5rSU9uM2xNdVd2eElQRnJrUTRILTZORDV2LWE1a0hFUlVfZ0xWZw?oc=5", "source_name": "Market source", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals (RXRX) Up 16.2% Since Last Earnings Report: Can It Continue?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxObk5Dbkc3Y0xPSURiQVFuRzRHdHl2b0dDMEIzM3ZrN2x3ZDlKNFA1b1FPRHpMb2Z3MnBKV1NTdzMxSG5FNXpWT1JQd1JCR3NhVF9FZzZSeDZkeFhHSTUxcFVkRVY4Tm5pUEFjRXI4eE5IWW1YRktYUFg3ejZJcU9tNHhjanZ2eXNRT2FTRzdDZTJGUERWdXQ5VUljbDdjZTVPdmc?oc=5", "source_name": "Market source", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley Raises its Price Target on Recursion (RXRX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPU0lzTDZJZGZIeGdmS19oUllYdEM0bE5mRG5DNl9RYUwzT1oxeWNHbE85Q09ySUQ1MVVkV2U4RGNXRmRuQVVBMHJsTzlsbnVpVWpMSWRTeW9FZW5pMjNpbXJQODZ3ak1IUXBwZk9EUHBrUnVzbWJRcmFmLWZOSzN1ZlNXR1JoTm9idWxjOWhWelY1cTZ2MGVKZmNHWXVwaTVad3Z6SDRn?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals (RXRX) Stock Drops Despite Market Gains: Important Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQWWhnY0RTX2pXa1AwbnNXcXR3SHlLdFlfQjBlS0NtTVE3eUZ3WjJrTXhUbTgxeXdYaXJ4YnJ6REl4eWs5NnpISG9UWEg0aG13dmtsTHg0SU5wR0Q2MDAyc3djcThQSnlDaGRJQ25XQWdjb3NBa1g3VWJXNDNzY1FEMjJDenVfUXMyR0FLZEQ5UEgxLXRCcnlCY0p3ak1qY1dGOElTZUNCYjJ5REk?oc=5", "source_name": "Market source", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RXRX Stock: Why Did Nvidia Offload AI Drug Developer Recursion?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPNGd2VElrallVa05DLXNhR09rdWNwOUlTdi1GUHJBXzVneml5OWdfWXhNdHZzbVdvXzVoVGpwa3dia3o1TDA0YXB5aHZvR21qUFNNVnJHYXQ0TjJSbEpFZE5MV3prWDJZZ3JkTk9IMTlneHdOc2pVdmdVdTFCbExpeHF3ZmFJOEFpWmdCVjJKaUF2T0dVRWZTR3V3QUR6Zw?oc=5", "source_name": "CMC Markets", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has 'Reached An Inflection Point'", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNbzBrak5aTnJlR2Rnb2p6eWExR3Q5dnV4T1pyRkVjTk0xc0pEWklFLWpDMDdGdXU2Zkh6Y1lTQXRUMF9GaThKTFJXVFpiLXRuU0FZUWxBTlZkRFlLZ0phQnd2aFUyVnNVOWl0dGlkcHV6VG15bGludTBMMFp1dngxaGxNX1ZaSE5ZX25ZU2hEVzdmUnVjUmFmc1hBMW1Da253ZzZlSEtHNk9UNTFXNE5BUGp4RkpJZWNRQmpmWExTaVpMc0MxS1E?oc=5", "source_name": "Menafn", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nvidia Dumped Recursion Pharmaceuticals Stock. Should You?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNRWlyZll6MVJ5N09uc0daaDF5a25EYk12Qnh2YUZSTzJIRWN1V0gwRXQ1MWRNemt3SWpvc21LbW90dWgzQVNvMEh4OUxNMERVTGRlNGlGVk9Tb3NJbnlmajNhOGZjT1JoLVFvMXBSbFRCWE9pdXVvdVplblhocjg5TkdDY2pOT094VlRncFEyR3FWaWRxZzlDeDNmSjY1eHRG?oc=5", "source_name": "Barchart.com", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cathie Wood Is Doubling Down on Recursion Pharmaceuticals Stock. Should You Buy RXRX Here?", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPazJjMkZ5QmVqTHd6VmZpODRaMTdSQUQzWjh0OHY4ejVCVFdnN1p6alhWWWhqMTlfX1FTYjdnTjg3bk51QnpfeUo0TGdDWDVlNHdRanJyaml4eEIybUtwVkNQbFRnYWdULURDUGpjN08yZjhpM0kxcFBVVWJwbDB4QXZCS0ZLeTdVSmVSN0l3blBESS1Iem1FQnNwVkszZUp6OVZVMWtDNG9ObEhydFdybWJpYUV5cmIyX0dmV3dkN1EtSlFVUnhCUngxZnZsUQ?oc=5", "source_name": "Barchart.com", "published_at": "2025-12-24T08:00:00+00:00", "published_display": "24 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oracle, Hut 8, Processa Pharmaceuticals, Recursion Pharmaceuticals, Udemy: Stocks Making The Biggest Moves Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPeDZPLTdWSXo5aHFadkN2a29oSWprcmt4WVYwTksxSXFaUGFUV2xNLVNjWDI3d0t5aUIydk1WV2RfV3lOckZQS0dWU3k5X0hRLVAyMHRZbXJmN0VIdVhmZnNLLXJBUGJ4bVdsVGJzYTAyQ1ZvYzdRVURnVzRBSFdicEVDMjRySmNlZnVxLW84djBqUjE5dmVFZE81cVBRd25mWjBMcWZ2TEozZkp2TU5wSFk5bnp0N0EtSkE?oc=5", "source_name": "Stocktwits", "published_at": "2025-12-17T08:00:00+00:00", "published_display": "17 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals Stock: Growth or Bubble?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNUGJuLVBFVnU2a19ZM05tdzhZZHFyOHh3aXVLU2tHSEpONHJvTmtvTEFpMVU3ZFIxSDFoQjR5Z2thcnBlcy0zQlBKeUd0ZEVoc2h2bjFLdWwzSDF1N282ckxMREJCeUxjSmh6c2tLVEZRamhtSWU0bGpaY0NUUkx5Z09oNnZkMG8xaEE?oc=5", "source_name": "StocksToTrade", "published_at": "2025-10-22T07:00:00+00:00", "published_display": "22 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tempus AI (TEM) vs. Recursion (RXRX): Which AI Biotech Stock Is Better?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNZ2xsckxkTVFVU2hPeHdLcjBQR0cwYnhCdXJLajVIY1UzNHUwakpFZmtpSDF4dHZkalBSS2JpYXNmajVzRllKOV9fLVdWbkhjSFA2Nl9jSGNHd083c2JwZ05sZHBVUkl6UDQwZVNGbnZjMWVwUDFQODJBRU5zdDZLaTdaTElwdS1RX0xiYlVwUlhFUEtoMzhKaEhWQlE3dmtyRV9zT19XcEZTZ2pM?oc=5", "source_name": "24/7 Wall St.", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals Stock Price Forecast. Should You Buy RXRX?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTE01VFBYVXh6X3owY052bGxSOV9yRGs2bzNpWjN2eXVBeHdxX2g0Z0RyUE1DXzB5NjlGandfNnd2eFZvRW5CeXRUVQ?oc=5", "source_name": "StockInvest.us", "published_at": "2021-04-27T19:48:12+00:00", "published_display": "27 Apr 2021 19:48", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals Announces Pricing of Initial Public Offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNR0N0Vmc3aEZTMlVZRFFyMVlvVEpjM2RXbkJJRzk0WXBDaEliVHNNU0lhLWROdTI3TnhJR1FWUTBTa3owclhhVmpxcVFxLWtld3c3aXJmcDlCbjlpa3c2aGtaZGdGOVVXTWlwWE9WNXhMVHN0ODM5VE1jRV93UndHYkp4WWlBY0xYRlhRVjcwOWRYcGZlVm5VZzVwclN6WGh4eDNwQ1RaVjhQZ0Z4VG1fVmIzdnZiS0lfR2lBNHJ0YWN4S0Nt?oc=5", "source_name": "PR Newswire", "published_at": "2021-04-16T07:00:00+00:00", "published_display": "16 Apr 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recursion Pharmaceuticals Jumps in Debut After $436 Million IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOOE1VbEVtVGFYZVBVVFc4RFFUY2ZPNEJiVmZUcnVPaWZpbVAwZVA5MzNvYURkTS1qOFZjSXl0UmsxZFpIR3ZuUDZGdEJDMG9uNWoxcFNodXpPblhWaEs2S2E1bDJaY1dHdUhsa2FkaFhVZ1dzeVpoMV9tc25oSFhZdVNtTU1sd3ozYmhmZHByanRpRElCOTUxU0dnMjlhazdUblhLV0lFUlI0M1J3MDNyUkJjRQ?oc=5", "source_name": "Bloomberg.com", "published_at": "2021-04-16T07:00:00+00:00", "published_display": "16 Apr 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 83, "total_relevant": 26, "sentiment_summary": {"positive": 10, "negative": 3, "neutral": 13, "score": 52, "total": 26, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 91, "events": [{"event": "general", "label": "Market update", "weight": 13.0, "count": 23}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 10, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 52.77, "latest_week": "2026-07-17", "one_week_move": -15.2, "four_week_move": -4.9, "twelve_week_move": -17.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.695532, "market_dynamics_buy_signal": false, "relative_strength": -34.283406, "fair_value_gap": -41.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 26.7249, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-15.2% over one week, -4.9% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 9}, {"label": "Quiver Quantitative", "count": 3}, {"label": "The Motley Fool", "count": 3}, {"label": "Stocktwits", "count": 2}, {"label": "Barchart.com", "count": 2}, {"label": "CMC Markets", "count": 1}, {"label": "Menafn", "count": 1}, {"label": "StocksToTrade", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 26}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 23}, {"label": "Earnings", "count": 1}, {"label": "Analyst action", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "91/100 classification confidence."}, {"label": "Company focus", "value": "26", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-15.2% over one week, -4.9% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Recursion Pharmaceuticals Stock Short Interest Falls to 34.41%"}], "updated_at": "2026-07-21T17:41:43.953255+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}